We could show that targeting the early steps of platelet adherence to vessel walls via glycoprotein (GP) Ibα–von Willebrand factor (vWF) interactions can delay progressive brain infarctions by blocking platelet–lymphocyte responses [4,5,6]. The gene discussed is VWF; the disease is brain infarction.